Standard Operating Procedure for New Product Registration Planning
| Department | Regulatory Affairs |
| SOP No. | RA/2026/644 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 09/04/2026 |
| Effective Date | 09/04/2026 |
| Review Date | 09/04/2028 |
Purpose
This Standard Operating Procedure (SOP) outlines the systematic approach for planning new product registrations within regulated markets. It aims to ensure that all necessary regulatory requirements, documentation, timelines, and resource allocations are identified and managed efficiently to achieve timely market entry. This SOP supports compliance with applicable regulatory frameworks and promotes standardized regulatory affairs practices to minimize delays, ensure quality, and facilitate audit readiness.
Scope
This SOP covers the planning activities related to new product registration submissions across all dosage forms, therapeutic categories, and regions applicable to the organization. It applies to the identification of regulatory requirements, preparation of registration strategies, coordination of cross-functional inputs, and establishment of timelines. This SOP excludes the detailed compilation and submission of dossiers, post-approval variations, and maintenance activities.
Responsibilities
The following functional roles are involved:
- Regulatory Affairs Team – responsible for preparing the registration plan, gathering regulatory intelligence, and coordinating inputs.
- Quality Assurance – reviewing compliance aspects and approving the registration strategy.
- Project Management – overseeing timelines and resource allocation.
- Manufacturing, R&D, and Legal teams – providing necessary technical and compliance information.
- Regulatory Manager – reviewing and endorsing the plan prior to implementation.
Accountability
The Regulatory Affairs Head is accountable for the overall implementation, compliance, periodic review, escalation of issues, and effectiveness of this SOP. They ensure consistent application, update the SOP as necessary, and provide necessary training.
Procedure
1. Initiation and Requirement Gathering:
Upon identification of a new product for registration, the Regulatory Affairs team initiates planning by gathering all relevant information, including product details, intended markets, applicable regulations, and timelines.
2. Regulatory Intelligence and Gap Analysis:
Perform comprehensive regulatory intelligence to understand submission requirements, dossier formats, data expectations, and any country-specific conditions. Identify gaps between available data and regulatory needs.
3. Cross-Functional Coordination:
Engage with manufacturing, quality, R&D, and legal to collect necessary technical documentation, stability data, validation status, certificates, and compliance statements for dossier preparation.
4. Registration Strategy Development:
Develop a detailed registration plan outlining submission timelines, target markets, dossier formats, resource assignments, risk assessments, and contingency plans.
5. Documentation and Approvals:
Document the registration plan in a formal Registration Planning Document (RPD). Circulate for review and approval by Quality Assurance, Regulatory Manager, and Project Management.
6. Execution Preparation:
Once approved, communicate the plan across teams. Establish tracking mechanisms for milestones, deviations, and changes. Ensure training of involved personnel on applicable procedures and compliance expectations.
7. Monitoring and Review:
Regularly monitor progress against the plan. Manage deviations or unexpected regulatory changes through documented change controls. Update the plan as required and maintain all records.
8. Closure:
Upon successful submission and acceptance of registration dossiers, archive the planning documents and conduct a review meeting to capture lessons learned and improve future planning cycles.
This procedure ensures robust, compliant, and transparent planning for new product registrations to facilitate efficient regulatory submissions and market approvals.
Abbreviations
RPD – Registration Planning Document
GMP – Good Manufacturing Practice
QA – Quality Assurance
R&D – Research and Development
RA – Regulatory Affairs
Documents
- Registration Planning Document (Annexure-1)
- Regulatory Intelligence Summary Report (Annexure-2)
- Cross-Functional Coordination Checklist (Annexure-3)
References
International Council for Harmonisation (ICH) Guidelines, FDA Regulations 21 CFR Parts 210 and 211, EMA Regulatory Guidance Documents, WHO GMP Guidelines, Internal Quality Management System Policies, Pharmacopoeial Standards relevant to the product.
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Registration Planning Document
Purpose: To outline a detailed plan for the new product registration including regulatory requirements, timelines, resources, and responsible parties.
| Product Name | Example Product A |
| Dosage Form | Tablet |
| Intended Markets | USA, EU, Japan |
| Submission Type | New Drug Application (NDA) |
| Key Milestones | Preparation Start: 10/04/2026 Data Collection Completion: 15/05/2026 Submission Target Date: 01/09/2026 |
| Responsible Persons | Regulatory Affairs Lead, Quality Assurance Reviewer, Project Manager |
| Risk Assessment Summary | Data gaps identified in stability studies; mitigation plan initiated. |
| Approval Status | Pending |
Annexure-2: Regulatory Intelligence Summary Report
Purpose: To summarize key regulatory requirements and submission guidelines for targeted markets.
| Country | Regulatory Authority | Submission Guidelines | Notes |
| USA | FDA | 21 CFR Parts 210 & 211; eCTD format required | Priority review option available |
| EU | EMA | CTD format; centralized procedure recommended | Additional environmental impact assessment needed |
| Japan | PMDA | CTD format; local language dossier required | Consultation meetings advised pre-submission |
Annexure-3: Cross-Functional Coordination Checklist
Purpose: To verify collection and completion of necessary documentation and inputs from different departments for registration planning.
| Department | Document/Information Required | Status | Comments |
|---|---|---|---|
| Manufacturing | Process validation reports; batch records | Completed | |
| Quality Assurance | QC specifications; stability data | In Progress | Stability data pending |
| Research & Development | Formulation details; clinical data summary | Completed | |
| Legal | Compliance certificates; patent status | Completed |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 09/04/2026 | 1.0 | Initial issue | New SOP creation |